ML17102B375
| ML17102B375 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 04/17/2017 |
| From: | Steven Lynch NRC/NRR/DPR/PRLB |
| To: | Piefer G SHINE Medical Technologies |
| Lynch S | |
| References | |
| Download: ML17102B375 (1) | |
Text
April 17, 2017 Gregory Piefer, Ph.D.
Chief Executive Officer SHINE Medical Technologies, Inc.
101 E. Milwaukee Street, Suite 600 Janesville, WI 53545
SUBJECT:
SHINE MEDICAL TECHNOLOGIES, INC. - ACKNOWLEDGMENT OF CHANGE OF MAILING ADDRESS
Dear Dr. Piefer:
By letter dated December 9, 2016 (Agencywide Documents Access and Management System
[ADAMS] Accession No. ML16344A021), SHINE Medical Technologies, Inc. (SHINE) informed the U.S. Nuclear Regulatory Commission (NRC) of a change in its mailing address.
The NRC has updated its records to reflect this change and will send all correspondence to the following mailing address:
SHINE Medical Technologies, Inc.
101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 If you have any questions, please contact Steven Lynch at 301-415-1524, or by electronic mail at Steven.Lynch@nrc.gov.
Sincerely,
/RA/
Steven T. Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-608
ML17102B375; *concurred via email NRR-088 OFFICE NRR/DPR/PRLB/PM*
NRR/DPR/PROB/LA*
NRR/DPR/PRLB/BC NAME SLynch NParker AAdams DATE 4/13/17 4/13/17 4/17/17